IVITX
Price
$20.08
Change
-$0.27 (-1.33%)
Updated
Nov 13 closing price
Net Assets
158.19M
VIVAX
Price
$73.17
Change
-$0.74 (-1.00%)
Updated
Nov 13 closing price
Net Assets
207.95B
Interact to see
Advertisement

IVITX vs VIVAX

Header iconIVITX vs VIVAX Comparison
Open Charts IVITX vs VIVAXBanner chart's image
VY® Invesco Growth and Income S2
Price$20.08
Change-$0.27 (-1.33%)
VolumeN/A
Net Assets158.19M
Vanguard Value Index I
Price$73.17
Change-$0.74 (-1.00%)
VolumeN/A
Net Assets207.95B
IVITX vs VIVAX Comparison Chart in %
View a ticker or compare two or three
VS
IVITX vs. VIVAX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVITX is a StrongBuy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 208B vs. IVITX (158M). VIVAX pays higher dividends than IVITX: VIVAX (1.98) vs IVITX (0.48). IVITX was incepted earlier than VIVAX: IVITX (23 years) vs VIVAX (33 years). IVITX (1.04) is less costly to investors than VIVAX (0.17). IVITX is a more actively managed with annual turnover of: 30.00 vs. VIVAX (9.00). IVITX has a lower initial minimum investment than VIVAX: IVITX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 6.68 vs. IVITX (-12.08). VIVAX return over 5 years is better than : 66.34 vs. IVITX (10.51).
IVITXVIVAXIVITX / VIVAX
Total Expense Ratio1.040.17612%
Annual Report Gross Expense Ratio1.040.17612%
Fund Existence23 years33 years-
Gain YTD-7.88411.965-66%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets158M208B0%
Annual Yield % from dividends0.481.9824%
Returns for 1 year-12.086.68-181%
Returns for 3 years-3.2733.49-10%
Returns for 5 years10.5166.3416%
Returns for 10 years-7.77135.00-6%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHSSX72.420.69
+0.96%
BlackRock Health Sciences Opps Instl
VFMFX45.840.26
+0.57%
Vanguard US Multifactor Admiral™
CSVAX23.030.11
+0.48%
Columbia International Div Inc A
ALCBX13.41N/A
N/A
ALPS/Smith Balanced Opportunity C
FIJYX40.72N/A
N/A
Fidelity Advisor Biotechnology Z